Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Voets, Guido M ^a   Platteel, Tamara N ^a,b   Fluit, Ad C ^a   Scharringa, Jelle ^a   Schapendonk, Claudia M ^a   Stuart, James Cohen ^a   Bonten, Marc J M ^a   Hall, Maurine A L ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SALTRO   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; NITROFURANTOIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIALES; GENE MUTATION; GENOTYPE; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; POPULATION DISTRIBUTION; PROMOTER REGION; PROTEUS MIRABILIS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; ENTEROBACTERIACEAE; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NETHERLANDS; YOUNG ADULT;

ENTEROBACTERIACEAE;

EID: 84871430570     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052102     Document Type: Article

References (30)

1. Gniadkowski M, (2008) Evolution of extended-spectrum beta-lactamases by mutation. Clin Microbiol Infect 14Suppl 1: 11-32.
2. Paterson DL, Bonomo RA, (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686.
3. Jacoby GA, (2009) AmpC beta-lactamases. Clin Microbiol Rev 22: 161-182.
4. Luzzaro F, Mezzatesta M, Mugnaioli C, Perilli M, Stefani S, et al. (2006) Trends in production of extended-spectrum beta-lactamases among Enterobacteriacae of medical interest: report of the second Italian nationwide survey. J Clin Microbiol 44: 1659-1664.
5. Mulvey MR, Bryce E, Boyd DA, Ofner-Agostini M, Land AM, et al. (2005) Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother 49: 358-365.
6. Galas M, Decousser JW, Breton N, Godard T, Allouch PY, et al. (2008) Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in France. Antimicrob Agents Chemother 52: 786-789.
7. Empel J, Baraniak A, Literacka E, Mrowka A, Fiett J, et al. (2008) Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother 52: 2449-2454.
8. Zhanel GG, Decorby M, Adam H, Mulvey MR, McCracken M, et al. (2010) Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob Agents Chemother 54: 4684-4693.
9. Sturm PD, Bochum ET, van Mook-Vermulst SV, Handgraaf C, Klaassen T, et al. (2010) Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. Microb Drug Resist 16: 55-60.
10. Wiegand I, Geiss HK, Mack D, Sturenburg E, Seifert H, (2007) Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol 45: 1167-1174.
11. Olesen I, Hasman H, Aarestrup FM, (2004) Prevalence of beta-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark. Microb Drug Resist 10: 334-340.
12. Naiemi NA, Duim B, Savelkoul PH, Spanjaard L, de Jonge E, et al. (2005) Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 43: 4862-4864.
13. Paauw A, Fluit AC, Verhoef J, Leverstein-van Hall MA, (2006) Enterobacter cloacae outbreak and emergence of quinolone resistance gene in Dutch hospital. Emerg Infect Dis 12: 807-812.
14. Voets GM, Fluit AC, Scharringa J, Cohen Stuart J, Leverstein-van Hall MA, (2011) A set of multiplex PCRs for genotypic detection of extended-spectrum beta-lactamases, carbapenemases, plasmid-mediated AmpC beta-lactamases and OXA beta-lactamases. Int J Antimicrob Agents 34: 356-359.
15. Rottman M, Benzerara Y, Hanau-Bercot B, Bizet C, Philippon A, et al. (2002) Chromosomal ampC genes in Enterobacter species other than Enterobacter cloacae, and ancestral association of the ACT-1 plasmid-encoded cephalosporinase to Enterobacter asburiae. FEMS Microbiol Lett 210: 87-92.
16. Caroff N, Espaze E, Berard I, Richet H, Reynaud A, (1999) Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production. FEMS Microbiol Lett 173: 459-465.
17. Haldorsen B, Aasnaes B, Dahl KH, Hanssen AM, Simonsen GS, et al. (2008) The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. J Antimicrob Chemother 62: 694-702.
18. Siu LK, Lu PL, Chen JY, Lin FM, Chang SC, (2003) High-level expression of AmpC beta-lactamase due to insertion of nucleotides between-10 and-35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment. Antimicrob Agents Chemother 47: 2138-2144.
19. Fluit AC, Terlingen AM, Andriessen L, Ikawaty R, van Mansfeld R, et al. (2010) Evaluation of the DiversiLab system for detection of hospital outbreaks of infections by different bacterial species. J Clin Microbiol 48: 3979-3989.
20. Brigante G, Luzzaro F, Perilli M, Lombardi G, Coli A, et al. (2005) Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int J Antimicrob Agents 25: 157-162.
21. Paniagua R, Valverde A, Coque TM, Baquero F, Canton R, (2010) Assessment of prevalence and changing epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae fecal carriers using a chromogenic medium. Diagn Microbiol Infect Dis 67: 376-379.
22. Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, et al. (2011) Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother 66: 37-47.
23. Platell JL, Johnson JR, Cobbold RN, Trott DJ, (2011) Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol 153: 99-108.
24. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, et al. (2011) Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 17: 873-880.
25. Woodford N, Reddy S, Fagan EJ, Hill RL, Hopkins KL, et al. (2007) Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J Antimicrob Chemother 59: 102-105.
26. Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, et al. (2008) Diversity of extended-spectrum beta-lactamases and class C beta-lactamases among cloacal Escherichia coli Isolates in Belgian broiler farms. Antimicrob Agents Chemother 52: 1238-1243.
27. Dierikx C, van Essen-Zandbergen A, Veldman K, Smith H, Mevius D, (2010) Increased detection of extended spectrum beta-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry. Vet Microbiol 145: 273-278.
28. Cortes P, Blanc V, Mora A, Dahbi G, Blanco JE, et al. (2010) Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl Environ Microbiol 76: 2799-2805.
29. Corvec S, Cremet L, Leprince C, Dauvergne S, Reynaud A, et al. (2010) Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic beta-lactamase during a 5-year period in a French teaching Hospital. Diagn Microbiol Infect Dis 67: 277-281.
30. Bogaerts P, Rodriguez-Villalobos H, Bauraing C, Deplano A, Laurent C, et al. (2010) Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals. Pathol Biol (Paris) 58: 78-83.